Functional and Pharmacological Implications of mGluR Heteromerization
mGluR 异聚化的功能和药理学意义
基本信息
- 批准号:8452668
- 负责人:
- 金额:$ 28.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-04-03 至 2017-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAgonistAmericanAutistic DisorderBindingBiochemicalBiological AssayCalcium ChannelCalcium SignalingCell fusionCellsClinicalColorComplementary DNAComplexDataDimerizationDiseaseDrug TargetingElectrophysiology (science)EpilepsyFamilyFluorescenceFluorescence Recovery After PhotobleachingG-Protein-Coupled ReceptorsGTP-Binding ProteinsGlutamatesHela CellsInjection of therapeutic agentLeadLigand BindingLinkLiteratureMediatingMetabotropic Glutamate ReceptorsModelingMolecularNervous system structureNeuraxisNeuronsPainPathologic ProcessesPathologyPathway interactionsPharmacologyPhospholipase CPhysiologicalPhysiological ProcessesPlayPropertyProtein FamilyPublic HealthRattusReceptor SignalingRoleSchizophreniaSignal TransductionSmall Interfering RNASpectrum AnalysisStructure of superior cervical ganglionSystemTestingTherapeuticTransfectionbasedimerinnovationinterestknock-downmembermulti-photonnovelpatch clampreceptorresearch studystoichiometrytherapeutic targettool
项目摘要
DESCRIPTION (provided by applicant): G protein coupled receptors (GPCRs) are the most frequently targeted protein family in clinical therapeutics. The molecular interactions between GPCRs can have a profound impact on their function and on the effects of drugs that target them. We examined the functional and pharmacological effects of interactions between two glutamate-activated GPCRs called mGluR1 and mGluR5, which are known to form homodimeric complexes (mGluR1-mGluR1 and mGluR5-mGluR5 dimers), are involved in many patho-physiological processes, and have widespread distribution in the central nervous system. Our data suggest that these receptors can interact functionally, and that this interaction alters their
sensitivity to selective pharmacological agents that target them. We suggest a novel hypothesis to explain this interaction in which mGluR1 and mGluR5 dimers combine to form tetrameric (or possibly larger) complexes with the ability to trans-activate, such that ligand binding to one receptor may activate G protein through the other. Further, these putative tetrameric receptors seem to respond to some pharmacological agents differently than their homodimeric constituents. To address this hypothesis, we will pursue the following Specific Aims: 1) To characterize the unique pharmacological properties of mGluR1/5 heteromers using the rat superior cervical ganglion (SCG) neuronal expression system, 2) To confirm the pharmacological and signaling properties of mGluR1/5 heteromers by expression in HeLa cells and using a different effectors to assay receptor signaling, 3) To directly assess the ability of fluorescently-tagged mGluR1, mGluR5 and both receptors together to form dimeric, tetrameric, or higher order multimeric receptors using multi-photon Fluorescence Recovery After Photobleaching (FRAP) and Fluorescence Correlation Spectroscopy (FCS), and 4) To verify the physiological relevance of functional mGluR interactions in neurons that natively express both mGluR1 and mGluR5.
描述(由申请人提供):G蛋白偶联受体(GPCR)是临床疗法中最常见的靶向蛋白质家族。 GPCR之间的分子相互作用可以对它们的功能以及针对它们的药物的影响产生深远的影响。我们研究了称为Mglur1和Mglur5的两个谷氨酸激活的GPCR之间相互作用的功能和药理效应,已知它们形成同型二聚体复合物(MGLUR1-MGLUR1和MGLUR5-MGLUR5二聚体),与许多病理学过程中的分布相关,并且具有广泛的分布。我们的数据表明这些受体可以在功能上相互作用,并且这种相互作用改变了它们
对目标的选择性药理学剂的敏感性。我们提出了一种新的假设来解释这种相互作用,其中mGlUR1和MGLUR5二聚体结合形成四聚体(或可能更大的)复合物具有反式激活的能力,因此配体与一种受体的结合可以通过另一个受体激活G蛋白。此外,这些推定的四聚体受体似乎对某些药理剂的反应与同二聚体成分不同。为了解决这一假设,我们将追求以下具体目的:1)使用大鼠上颈神经节(SCG)神经元表达系统来表征MGLUR1/5异构体的独特药理特性,2)确认以外的效率效应的MGLUR1/5杂体的药理和信号的效率,以确认药物学和信号的特性,以使效率效应效率效应,以实现3个效率的效率,以实现3个效率的效率,并使用效率效应效应效应。 fluorescently-tagged mGluR1, mGluR5 and both receptors together to form dimeric, tetrameric, or higher order multimeric receptors using multi-photon Fluorescence Recovery After Photobleaching (FRAP) and Fluorescence Correlation Spectroscopy (FCS), and 4) To verify the physiological relevance of functional mGluR interactions in neurons that natively express both mGluR1 and mglur5。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul J. Kammermeier其他文献
Determining the Topology of the Acid-Sensing Ion Channel Intracellular Domains
- DOI:
10.1016/j.bpj.2020.11.2112 - 发表时间:
2021-02-12 - 期刊:
- 影响因子:
- 作者:
Tyler A. Couch;Kyle Berger;Dana Kneisley;Matthew L. Rook;Tyler W. McCullock;Paul J. Kammermeier;David M. MacLean - 通讯作者:
David M. MacLean
Investigating the Heteromerization of Metabotropic Glutamate Receptors using a Novel Single Molecule Imaging Method
- DOI:
10.1016/j.bpj.2017.11.2903 - 发表时间:
2018-02-02 - 期刊:
- 影响因子:
- 作者:
Alexander L. Van Slyke;Avtar Singth;Nitya Deshmukh;Paul J. Kammermeier;Warren R. Zipfel - 通讯作者:
Warren R. Zipfel
Paul J. Kammermeier的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul J. Kammermeier', 18)}}的其他基金
A novel system for controlling dimeric receptor composition to discover unique heterodimer pharmacology
控制二聚体受体组成的新系统,以发现独特的异二聚体药理学
- 批准号:
10735066 - 财政年份:2023
- 资助金额:
$ 28.42万 - 项目类别:
Tools for studying the regulation of Homer protein splicing
研究荷马蛋白剪接调节的工具
- 批准号:
10349911 - 财政年份:2021
- 资助金额:
$ 28.42万 - 项目类别:
Functional and Pharmacological Implications of mGluR Heteromerization
mGluR 异聚化的功能和药理学意义
- 批准号:
8643265 - 财政年份:2012
- 资助金额:
$ 28.42万 - 项目类别:
Functional and Pharmacological Implications of mGluR Heteromerization
mGluR 异聚化的功能和药理学意义
- 批准号:
9036403 - 财政年份:2012
- 资助金额:
$ 28.42万 - 项目类别:
Functional and Pharmacological Implications of mGluR Heteromerization
mGluR 异聚化的功能和药理学意义
- 批准号:
8829302 - 财政年份:2012
- 资助金额:
$ 28.42万 - 项目类别:
Functional and Pharmacological Implications of mGluR Heteromerization
mGluR 异聚化的功能和药理学意义
- 批准号:
8270968 - 财政年份:2012
- 资助金额:
$ 28.42万 - 项目类别:
Functional and Pharmacological Implications of mGluR Heteromerization
mGluR 异聚化的功能和药理学意义
- 批准号:
8726532 - 财政年份:2012
- 资助金额:
$ 28.42万 - 项目类别:
相似国自然基金
β2AR激动剂与微秒电刺激对大鼠肛提肌线粒体有氧代谢酶及其多模态影像表型的影响研究
- 批准号:82101697
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
β2AR激动剂与微秒电刺激对大鼠肛提肌线粒体有氧代谢酶及其多模态影像表型的影响研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
环境激素壬基酚对变应性鼻炎的影响及其对GPER特异性激动剂G-1在变应性鼻炎治疗作用中的干扰机制研究
- 批准号:82000963
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
促生长激素释放激素激动剂抑制平滑肌细胞转分化对动脉粥样硬化的影响及机制研究
- 批准号:81900389
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
五羟色胺2C受体激动剂对2型糖尿病小鼠β细胞功能的影响及机制研究
- 批准号:81803644
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The role of nigrostriatal and striatal cell subtype signaling in behavioral impairments related to schizophrenia
黑质纹状体和纹状体细胞亚型信号传导在精神分裂症相关行为障碍中的作用
- 批准号:
10751224 - 财政年份:2024
- 资助金额:
$ 28.42万 - 项目类别:
Dravet Syndrome Anti-Epileptic Control by Targeting GIRK Channels
通过针对 GIRK 通道进行 Dravet 综合征抗癫痫控制
- 批准号:
10638439 - 财政年份:2023
- 资助金额:
$ 28.42万 - 项目类别:
The role of core circadian regulator Bmal1 in axonal regeneration and nerve repair
核心昼夜节律调节因子 Bmal1 在轴突再生和神经修复中的作用
- 批准号:
10677932 - 财政年份:2023
- 资助金额:
$ 28.42万 - 项目类别:
Stabilizing the tripartite synaptic complex following TBI
TBI 后稳定三方突触复合体
- 批准号:
10844877 - 财政年份:2023
- 资助金额:
$ 28.42万 - 项目类别:
Targeting Trained Immunity in Trauma-Induced Immune Dysregulation
针对创伤引起的免疫失调中训练有素的免疫力
- 批准号:
10714384 - 财政年份:2023
- 资助金额:
$ 28.42万 - 项目类别: